• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特定IgG-SMAP28偶联物在混合培养物中对牙龈卟啉单胞菌的靶向抗菌活性。

Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture.

作者信息

Franzman Michael R, Burnell Kindra K, Dehkordi-Vakil Farideh H, Guthmiller Janet M, Dawson Deborah V, Brogden Kim A

机构信息

Department of Periodontics, College of Dentistry, The University of Iowa, Iowa City, IA 52242, USA.

出版信息

Int J Antimicrob Agents. 2009 Jan;33(1):14-20. doi: 10.1016/j.ijantimicag.2008.05.021. Epub 2008 Sep 7.

DOI:10.1016/j.ijantimicag.2008.05.021
PMID:18778918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3169388/
Abstract

Antimicrobial peptides coupled to a ligand, receptor or antibody for a specific pathogenic bacteria could be used to develop narrow-spectrum pharmaceuticals with 'targeted' antimicrobial activity void of adverse reactions often associated with the use of broad-spectrum antibiotics. To assess the feasibility of this approach, in this study sheep myeloid antimicrobial peptide (SMAP) 28 was linked to affinity- and protein G-purified rabbit immunoglobulin G (IgG) antibodies specific to the outer surface of Porphyromonas gingivalis strain 381. The selective activity of the P. gingivalis IgG-SMAP28 conjugate was then assessed by adding it to an artificially generated microbial community containing P. gingivalis, Aggregatibacter actinomycetemcomitans and Peptostreptococcus micros. The specificity of the P. gingivalis IgG-SMAP28 conjugate in this mixed culture was concentration-dependent. The conjugate at 50 microg protein/mL lacked specificity and killed P. gingivalis, A. actinomycetemcomitans and P. micros. The conjugate at 20 microg protein/mL was more specific and killed P. gingivalis. This is an initial step to develop a selective antimicrobial agent that can eliminate a specific periodontal pathogen, such as P. gingivalis, from patients with periodontal disease without harming the normal commensal flora.

摘要

与针对特定病原菌的配体、受体或抗体偶联的抗菌肽,可用于开发具有“靶向”抗菌活性的窄谱药物,这类药物没有使用广谱抗生素时常出现的不良反应。为评估该方法的可行性,在本研究中,将绵羊髓系抗菌肽(SMAP)28与经亲和纯化及蛋白G纯化的、针对牙龈卟啉单胞菌381株外表面的兔免疫球蛋白G(IgG)抗体相连接。然后,通过将牙龈卟啉单胞菌IgG-SMAP28偶联物添加到一个人工构建的包含牙龈卟啉单胞菌、伴放线聚集杆菌和微小消化链球菌的微生物群落中,来评估其选择性活性。在这种混合培养物中,牙龈卟啉单胞菌IgG-SMAP28偶联物的特异性呈浓度依赖性。蛋白质浓度为50微克/毫升的偶联物缺乏特异性,能杀死牙龈卟啉单胞菌、伴放线聚集杆菌和微小消化链球菌。蛋白质浓度为20微克/毫升的偶联物更具特异性,能杀死牙龈卟啉单胞菌。这是开发一种选择性抗菌剂的第一步,该抗菌剂能够在不损害正常共生菌群的情况下,从牙周病患者体内清除特定的牙周病原体,如牙龈卟啉单胞菌。

相似文献

1
Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture.特定IgG-SMAP28偶联物在混合培养物中对牙龈卟啉单胞菌的靶向抗菌活性。
Int J Antimicrob Agents. 2009 Jan;33(1):14-20. doi: 10.1016/j.ijantimicag.2008.05.021. Epub 2008 Sep 7.
2
Communication: Antimicrobial Activity of SMAP28 with a Targeting Domain for Porphyromonas gingivalis.通讯:具有针对牙龈卟啉单胞菌靶向结构域的SMAP28的抗菌活性
Probiotics Antimicrob Proteins. 2010 Mar 1;2(1):21-5. doi: 10.1007/s12602-009-9028-5.
3
SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes.SMAP29 同系物对口腔细菌具有活性,且对口腔角质形成细胞的毒性降低。
Oral Microbiol Immunol. 2008 Apr;23(2):89-95. doi: 10.1111/j.1399-302X.2007.00389.x.
4
Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.伴放线放线杆菌和牙龈卟啉单胞菌的龈下存在情况、种特异性血清免疫球蛋白G抗体水平与牙周炎疾病复发
J Periodontal Res. 2006 Jun;41(3):228-34. doi: 10.1111/j.1600-0765.2005.00860.x.
5
Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent.牙龈卟啉单胞菌ATCC 33277对抗菌肽直接杀伤作用的抗性与蛋白酶无关。
Antimicrob Agents Chemother. 2008 Feb;52(2):638-42. doi: 10.1128/AAC.01271-07. Epub 2007 Dec 17.
6
Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.阳离子十八肽AmyI-1-18及其氨基酸取代类似物对牙龈卟啉单胞菌的抗菌活性及作用机制
J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. Epub 2016 Jul 28.
7
Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.术前血清免疫球蛋白 G 和 A 抗体对牙龈卟啉单胞菌是食管鳞癌诊断和预后的潜在血清生物标志物。
BMC Cancer. 2018 Jan 3;18(1):17. doi: 10.1186/s12885-017-3905-1.
8
Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.慢性和侵袭性牙周炎中的中性粒细胞与牙龈卟啉单胞菌和伴放线聚集杆菌的相互作用
J Periodontal Res. 2009 Jun;44(3):368-77. doi: 10.1111/j.1600-0765.2008.01113.x. Epub 2009 Feb 6.
9
Dynamics of serum immunoglobulin G avidity for Porphyromonas gingivalis in adult periodontitis.成人牙周炎患者血清中牙龈卟啉单胞菌免疫球蛋白G亲和力的动态变化
J Periodontol. 1998 Mar;69(3):367-73. doi: 10.1902/jop.1998.69.3.367.
10
A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.牙龈蛋白酶R上的一个肽结构域,可赋予小鼠对牙龈卟啉单胞菌感染的免疫力。
Infect Immun. 1998 Sep;66(9):4108-14. doi: 10.1128/IAI.66.9.4108-4114.1998.

引用本文的文献

1
Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development.结合治疗性蛋白质作为治疗引发癌症发展的细菌的一种方法。
iScience. 2024 Sep 26;27(10):111029. doi: 10.1016/j.isci.2024.111029. eCollection 2024 Oct 18.
2
Antimicrobial Biomaterials Based on Physical and Physicochemical Action.基于物理和物理化学作用的抗菌生物材料
Adv Healthc Mater. 2024 Dec;13(32):e2402001. doi: 10.1002/adhm.202402001. Epub 2024 Sep 20.
3
Interconnections Between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance Between Systemic Health and Disease.口腔微生物群与肠道微生物群之间的相互联系:微生物失调的逆转以及全身健康与疾病之间的平衡
Microorganisms. 2021 Feb 26;9(3):496. doi: 10.3390/microorganisms9030496.
4
Antimicrobial Prosthetic Surfaces in the Oral Cavity-A Perspective on Creative Approaches.口腔中的抗菌修复表面——创新方法的视角
Microorganisms. 2020 Aug 17;8(8):1247. doi: 10.3390/microorganisms8081247.
5
Towards Robust Delivery of Antimicrobial Peptides to Combat Bacterial Resistance.迈向抗菌肽的稳健递送以对抗细菌耐药性。
Molecules. 2020 Jul 3;25(13):3048. doi: 10.3390/molecules25133048.
6
Repurposing AM404 for the treatment of oral infections by Porphyromonas gingivalis.将AM404重新用于治疗牙龈卟啉单胞菌引起的口腔感染。
Clin Exp Dent Res. 2017 Apr 7;3(2):69-76. doi: 10.1002/cre2.65. eCollection 2017 Apr.
7
Targeted antimicrobial therapy in the microbiome era.靶向抗菌治疗在微生物组时代。
Mol Oral Microbiol. 2017 Dec;32(6):446-454. doi: 10.1111/omi.12190. Epub 2017 Aug 1.
8
Design and Application of Antimicrobial Peptide Conjugates.抗菌肽缀合物的设计与应用
Int J Mol Sci. 2016 May 11;17(5):701. doi: 10.3390/ijms17050701.
9
Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.抗菌肽:预防和治疗龋齿的机遇
Probiotics Antimicrob Proteins. 2011 Jun;3(2):68. doi: 10.1007/s12602-011-9076-5.
10
Pro-moieties of antimicrobial peptide prodrugs.抗菌肽前药的前体部分。
Molecules. 2015 Jan 13;20(1):1210-27. doi: 10.3390/molecules20011210.

本文引用的文献

1
Antibiotics: the epitome of a wonder drug.
BMJ. 2007 Jan 6;334 Suppl 1:s6. doi: 10.1136/bmj.39021.640255.94.
2
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.抗菌肽和宿主防御肽作为新型抗感染治疗策略。
Nat Biotechnol. 2006 Dec;24(12):1551-7. doi: 10.1038/nbt1267.
3
Antibiotics--past, present, and future.抗生素——过去、现在与未来。
Med Clin North Am. 2006 Nov;90(6):1049-76. doi: 10.1016/j.mcna.2006.06.007.
4
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.用于治疗的抗菌肽:障碍与现实前景
Curr Opin Pharmacol. 2006 Oct;6(5):468-72. doi: 10.1016/j.coph.2006.04.006. Epub 2006 Aug 4.
5
Antimicrobial activity of Substance P and Neuropeptide Y against laboratory strains of bacteria and oral microorganisms.P物质和神经肽Y对实验室细菌菌株及口腔微生物的抗菌活性。
J Neuroimmunol. 2006 Aug;177(1-2):215-8. doi: 10.1016/j.jneuroim.2006.05.011. Epub 2006 Jun 30.
6
Experimental evolution of resistance to an antimicrobial peptide.对抗菌肽耐药性的实验性进化
Proc Biol Sci. 2006 Jan 22;273(1583):251-6. doi: 10.1098/rspb.2005.3301.
7
A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis.一种新型工程肽,一种窄谱抗生素,对耐万古霉素粪肠球菌有效。
Antimicrob Agents Chemother. 2005 Mar;49(3):1184-9. doi: 10.1128/AAC.49.3.1184-1189.2005.
8
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?抗菌肽:细菌中的成孔剂还是代谢抑制剂?
Nat Rev Microbiol. 2005 Mar;3(3):238-50. doi: 10.1038/nrmicro1098.
9
Induction of {beta}-defensin resistance in the oral anaerobe Porphyromonas gingivalis.口腔厌氧菌牙龈卟啉单胞菌中β-防御素抗性的诱导
Antimicrob Agents Chemother. 2005 Jan;49(1):183-7. doi: 10.1128/AAC.49.1.183-187.2005.
10
Systemic antibiotics in the management of chronic periodontitis.全身用抗生素在慢性牙周炎治疗中的应用
Eur J Prosthodont Restor Dent. 2004 Jun;12(2):63-9.